देश: संयुक्त राज्य
भाषा: अंग्रेज़ी
स्रोत: NLM (National Library of Medicine)
PROMETHAZINE HYDROCHLORIDE (UNII: R61ZEH7I1I) (PROMETHAZINE - UNII:FF28EJQ494), CODEINE PHOSPHATE (UNII: GSL05Y1MN6) (CODEINE ANHYDROUS - UNII:UX6OWY2V7J)
NuCare Pharmaceuticals,Inc.
PROMETHAZINE HYDROCHLORIDE
PROMETHAZINE HYDROCHLORIDE 6.25 mg in 5 mL
ORAL
PRESCRIPTION DRUG
Promethazine with Codeine Oral Solution is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. The combination of promethazine hydrochloride and codeine phosphate is contraindicated in pediatric patients less than 6 years of age, because the combination may cause fatal respiratory depression in this age population. Codeine sulfate is contraindicated for post-operative pain management in children who have undergone tonsillectomy and/or adenoidectomy. (See WARNINGS - Death Related to Ultra- Rapid Metabolism of Codeine to Morphine ). Codeine is contraindicated in patients with a known hypersensitivity to the drug. Promethazine hydrochloride is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. Antihistamines and codeine are both contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. Prometha
Promethazine with Codeine Oral Solution, a clear purple solution with odor of grape menthol, contains promethazine hydrochloride 6.25 mg/5 mL, codeine phosphate 10 mg/5 mL and alcohol 7 percent, and is available in 4 fluid ounce (120 mL) NDC 68071-4037-4 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container with a child-resistant closure as defined in the USP. DEA Order Form Required
Abbreviated New Drug Application
NuCare Pharmaceuticals,Inc. ---------- MEDICATION GUIDE Promethazine (proe meth’ a zeen) with Codeine (koe’ deen) Oral Solution C-V (Promethazine Hydrochloride and Codeine Phosphate Oral Solution) What is the most important information I should know about Promethazine with Codeine Oral Solution? • Taking Promethazine with Codeine Oral Solution with benzodiazepines, or other central nervous system depressants, including alcohol can cause severe drowsiness, breathing problems (respiratory depression), coma, and death. • Promethazine with Codeine Oral Solution can cause you to be drowsy. Avoid driving a car or operating machinery during treatment with Promethazine with Codeine Oral Solution. • Do not give Promethazine with Codeine Oral Solution to children who are under 6 years of age. It may harm them. • Do not give Promethazine with Codeine Oral Solution to a child to treat pain after tonsillectomy or adenoidectomy surgery. • When you take Promethazine with Codeine Oral Solution, some of it changes into morphine in your body. • In some children and adults this happens very quickly, and can cause you to stop breathing and cause death due to an overdose. • Women who breastfeed should talk to their healthcare provider before taking Promethazine with Codeine Oral Solution. • When you take Promethazine with Codeine Oral Solution, some of it changes into morphine in your body. • In some women, this happens very quickly. Codeine and morphine pass into your breast milk. A large amount of morphine can cause your baby to die. • Call your healthcare provider or get emergency medical help right away if anyone taking Promethazine with Codeine Oral Solution, or your breastfeeding baby has any of the symptoms below: • increased sleepiness • shallow breathing • confusion • limpness • difficulty breathing • your baby has difficulty breastfeeding • Keep Promethazine with Codeine Oral Solution in a safe place away from children. Accidental use by a child is a medical emergency and can cause deat पूरा दस्तावेज़ पढ़ें
PROMETHAZINE WITH CODEINE- PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE SOLUTION NUCARE PHARMACEUTICALS,INC. ---------- PROMETHAZINE WITH CODEINE ORAL SOLUTION (PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE ORAL SOLUTION) CV RX ONLY WARNING: RESPIRATORY DEPRESSION IN CHILDREN; DEATH RELATED TO ULTRA RAPID METABOLISM OF CODEINE TO MORPHINE AND RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS RESPIRATORY DEPRESSION IN CHILDREN THE COMBINATION OF PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE IS CONTRAINDICATED IN PEDIATRIC PATIENTS LESS THAN 6 YEARS OF AGE. CONCOMITANT ADMINISTRATION OF PROMETHAZINE PRODUCTS WITH OTHER RESPIRATORY DEPRESSANTS HAS AN ASSOCIATION WITH RESPIRATORY DEPRESSION, AND SOMETIMES DEATH, IN PEDIATRIC PATIENTS. POSTMARKETING CASES OF RESPIRATORY DEPRESSION, INCLUDING FATALITIES, HAVE BEEN REPORTED WITH USE OF PROMETHAZINE HYDROCHLORIDE IN PEDIATRIC PATIENTS LESS THAN 2 YEARS OF AGE. A WIDE RANGE OF WEIGHT-BASED DOSES OF PROMETHAZINE HYDROCHLORIDE HAVE RESULTED IN RESPIRATORY DEPRESSION IN THESE PATIENTS. DEATH RELATED TO ULTRA-RAPID METABOLISM OF CODEINE TO MORPHINE RESPIRATORY DEPRESSION AND DEATH HAVE OCCURRED IN CHILDREN WHO RECEIVED CODEINE FOLLOWING TONSILLECTOMY AND/OR ADENOIDECTOMY AND HAD EVIDENCE OF BEING ULTRA-RAPID METABOLIZERS OF CODEINE DUE TO A CYP2D6 POLYMORPHISM. RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS CONCOMITANT USE OF OPIOIDS WITH BENZODIAZEPINES OR OTHER CENTRAL NERVOUS SYSTEM (CNS) DEPRESSANTS, INCLUDING ALCOHOL, MAY RESULT IN PROFOUND SEDATION, RESPIRATORY DEPRESSION, COMA, AND DEATH (SEE WARNINGS, PRECAUTIONS - DRUG INTERACTIONS). AVOID USE OF OPIOID COUGH MEDICATIONS IN PATIENTS TAKING BENZODIAZEPINES, OTHER CNS DEPRESSANTS, OR ALCOHOL. DESCRIPTION Each 5 mL (one teaspoonful), for oral administration contains: Promethazine hydrochloride 6.25 mg; codeine phosphate 10 mg in a flavored syrup base with a pH between 4.4 and 5.2. Alcohol 7%. Inactive ingredients: Ascorbic acid, citric acid, FD&C blue #1, FD&C r पूरा दस्तावेज़ पढ़ें